STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS
Mark Identification

STABILISE SELECTIVE TREATMENT OF ATHEROSCLEROSIS: DARAPLADIB INIHIBITS LP-PLA2 WITH ANTI-INFLAMMATORY AND PLAQUE STABILISING EFFECTS

Serial Number

77309541

Filing Date

Oct 22, 2007

Trademark by

GLAXO GROUP LIMITED

Classification Information

Printed materials, namely, pamphlets and brochures featuring the treatment and prevention of cardiovascular diseases and disorders

Paper Goods and Printed Matter

Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders

Computer and Scientific